Status:
COMPLETED
Propofol-induced EEG Changes in Hypoxic Brain Injury
Lead Sponsor:
University of Oulu
Collaborating Sponsors:
Oulu University Hospital
Helsinki University Central Hospital
Conditions:
Hypoxic-Ischemic Encephalopathy
Cardiac Arrest
Eligibility:
All Genders
18+ years
Brief Summary
PROPEA3 is a prospective observational study investigating the recovery of propofol-induced EEG slow-wave activity and its association with neurological outcome after cardiac arrest.
Detailed Description
PROPEA3 is a prospective observational study investigating the recovery of propofol-induced EEG slow-wave activity and its association with neurological outcome after cardiac arrest. Comatose adult pa...
Eligibility Criteria
Inclusion
- Comatose patients admitted to intensive care after cardiac arrest
Exclusion
- Previous neurological disease expected to affect EEG substantially
Key Trial Info
Start Date :
October 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2019
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT03485781
Start Date
October 12 2017
End Date
July 10 2019
Last Update
March 25 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Central Hospital
Helsinki, Finland, 00029
2
Oulu University Hospital
Oulu, Finland, 90220